Up	B:C0041904
-Regulation	I:C0041904
of	O
Claudin	B:C0909824
-	I:C0909824
6	I:C0909824
in	O
the	O
Distal	B:C0205108
Lung	B:C0024109
Impacts	O
Secondhand	B:C0375734
Smoke	I:C0375734
-	O
Induced	O
Inflammation	B:C0021368
.	O

It	O
has	O
long	O
been	O
understood	O
that	O
increased	O
epithelial	O
permeability	O
contributes	O
to	O
inflammation	B:C0021368
observed	O
in	O
many	O
respiratory	B:C0035204
diseases	I:C0035204
.	O

Recently	O
,	O
evidence	O
has	O
revealed	O
that	O
environmental	B:C0014412
exposure	I:C0014412
to	O
noxious	O
material	O
such	O
as	O
cigarette	B:C0239059
smoke	I:C0239059
reduces	O
tight	B:C0242358
junction	I:C0242358
barrier	B:C0225694
integrity	O
,	O
thus	O
enhancing	O
inflammatory	O
conditions	O
.	O

Claudin	B:C0909824
-	I:C0909824
6	I:C0909824
(	O
Claudin	B:C0909824
-	I:C0909824
6	I:C0909824
)	O
is	O
a	O
tetraspanin	B:C0021699
transmembrane	I:C0021699
protein	I:C0021699
found	O
within	O
the	O
tight	B:C0229984
junctional	I:C0229984
complex	I:C0229984
and	O
is	O
implicated	O
in	O
maintaining	O
lung	B:C0225694
epithelial	I:C0225694
barriers	I:C0225694
.	O

To	O
test	O
the	O
hypothesis	O
that	O
increased	O
Claudin	B:C0909824
-	I:C0909824
6	I:C0909824
ameliorates	O
inflammation	B:C0021368
at	O
the	O
respiratory	B:C0225694
barrier	I:C0225694
,	O
we	O
utilized	O
the	O
Tet	O
-	O
On	O
inducible	O
transgenic	B:C0282641
system	I:C0282641
to	O
conditionally	O
over	B:C1514559
-	I:C1514559
express	I:C1514559
Clnd6	B:C1570898
in	O
the	O
distal	B:C0205108
lung	B:C0024109
.	O

Cldn6	B:C0025936
transgenic	I:C0025936
(	O
transgenic	B:C0025936
)	O
and	O
control	B:C1511501
mice	B:C0025929
were	O
continuously	O
provided	O
doxycycline	B:C0013090
from	O
postnatal	O
day	O
(	O
PN	O
)	O
30	O
until	O
euthanasia	B:C1136183
date	O
at	O
PN90	O
.	O

A	O
subset	O
of	O
Cldn6	B:C0025936
TG	I:C0025936
and	O
control	B:C1511501
mice	B:C0025929
were	O
also	O
subjected	O
to	O
daily	O
secondhand	B:C0375734
tobacco	I:C0375734
smoke	I:C0375734
(	O
secondhand	B:C0375734
tobacco	I:C0375734
smoke	I:C0375734
)	O
via	O
a	O
nose	B:C0028429
only	O
inhalation	B:C0460002
system	I:C0460002
from	O
PN30	O
-	O
90	O
and	O
compared	O
to	O
room	O
air	O
(	O
RA	O
)	O
controls	O
.	O

Animals	B:C0003062
were	O
euthanized	B:C1136183
on	O
PN90	O
and	O
lungs	B:C0024109
were	O
harvested	O
for	O
histological	O
and	O
molecular	O
characterization	O
.	O

Bronchoalveolar	B:C0006279
lavage	I:C0006279
fluid	I:C0006279
(	O
Bronchoalveolar	B:C0006279
lavage	I:C0006279
fluid	I:C0006279
)	O
was	O
procured	O
for	O
the	O
assessment	B:C0220825
of	O
inflammatory	B:C0440752
cells	I:C0440752
and	O
molecules	O
.	O

Quantitative	B:C0599161
RT	I:C0599161
-	I:C0599161
PCR	I:C0599161
and	O
immunoblotting	B:C0020985
revealed	O
increased	O
Claudin	B:C1570898
-	I:C1570898
6	I:C1570898
expression	B:C1171362
in	O
transgenic	B:C0025936
vs.	O
control	B:C1511501
animals	I:C1511501
and	O
secondhand	B:C0375734
tobacco	I:C0375734
smoke	I:C0375734
decreased	O
Claudin	B:C1570898
-	I:C1570898
6	I:C1570898
expression	B:C1171362
regardless	O
of	O
genetic	O
up	B:C0041904
-	I:C0041904
regulation	I:C0041904
.	O

Histological	O
evaluations	B:C0220825
revealed	O
no	O
adverse	O
pulmonary	B:C0024109
remodeling	O
via	O
Hematoxylin	B:C0523207
and	I:C0523207
Eosin	I:C0523207
(	I:C0523207
H&amp	I:C0523207
;	I:C0523207
E	I:C0523207
)	I:C0523207
staining	I:C0523207
or	O
any	O
qualitative	O
alterations	O
in	O
the	O
abundance	O
of	O
type	B:C0225700
II	I:C0225700
pneumocytes	I:C0225700
or	O
proximal	B:C0014597
non-ciliated	I:C0014597
epithelial	I:C0014597
cells	I:C0014597
via	O
staining	B:C0487602
for	O
cell	B:C0007634
specific	O
propeptide	B:C1454562
of	I:C1454562
Surfactant	I:C1454562
Protein	I:C1454562
-	I:C1454562
C	I:C1454562
(	O
propeptide	B:C1454562
of	I:C1454562
Surfactant	I:C1454562
Protein	I:C1454562
-	I:C1454562
C	I:C1454562
)	O
or	O
Club	B:C1505368
Cell	I:C1505368
Secretory	I:C1505368
Protein	I:C1505368
(	O
Club	B:C1505368
Cell	I:C1505368
Secretory	I:C1505368
Protein	I:C1505368
)	O
,	O
respectively	O
.	O

Immunoblotting	B:C0020985
and	O
qRT	B:C1514628
-	I:C1514628
PCR	I:C1514628
confirmed	O
the	O
differential	O
expression	B:C1171362
of	O
Claudin	B:C1570898
-	I:C1570898
6	I:C1570898
and	O
the	O
pro-inflammatory	B:C0021054
cytokines	I:C0021054
TNF-α	B:C0041368
and	O
IL	B:C0021753
-	I:C0021753
1	I:C0021753
β	I:C0021753
.	O

As	O
a	O
general	O
theme	O
,	O
inflammation	B:C0021368
induced	O
by	O
secondhand	B:C0375734
tobacco	I:C0375734
smoke	I:C0375734
exposure	B:C0243095
was	O
influenced	O
by	O
the	O
availability	O
of	O
Claudin	B:C1570898
-	I:C1570898
6	I:C1570898
.	O

These	O
data	O
reveal	O
captivating	O
information	O
suggesting	O
a	O
role	O
for	O
Claudin	B:C1570898
-	I:C1570898
6	I:C1570898
in	O
lungs	B:C0024109
exposed	B:C0243095
to	O
tobacco	B:C0439994
smoke	I:C0439994
.	O

Further	O
research	O
is	O
critically	O
necessary	O
in	O
order	O
to	O
fully	O
explain	O
roles	O
for	O
tight	B:C0229984
junctional	I:C0229984
components	I:C0229984
such	O
as	O
Claudin	B:C0909824
-	I:C0909824
6	I:C0909824
and	O
other	O
related	O
molecules	O
in	O
lungs	B:C0024109
coping	O
with	O
exposure	B:C0243095
.	O

